Skip to main content

Manchin calls election results a 'wake up call;' reacts to impact on Biden agenda

West Virginia Democrat is scared because people aren't saying, ‘This is good for our country'

West Virginia Democratic Sen. Joe Manchin spoke with Fox News' Bret Baier Wednesday on "Special Report" about the implications of the Virginia governor's election as well as the tight New Jersey race.

Republican Glenn Youngkin defeated former incumbent Democratic Gov. Terry McAuliffe in a neck-and-neck election widely seen as a referendum on President Joe Biden's policies. In New Jersey, the Democratic governor, Phil Murphy, is projected to win by a narrow margin against Republican Jack Ciattarelli. 

"I just saw it to confirm that we have a divided country … I hope it's a wake-up call for all of us," Manchin said. "I'm concerned. I've been talking about our debt, I've been talking about inflation, [and] I've been talking about the [economic] fallout we may have [from the spending bills]."

Democrats should pay more heed to the immediate needs of the American people, such as rising gas prices and infrastructure, according to Manchin. "Why don't we do more drilling and why don't we do more basically production in the United States? I'm not depending on OPEC. I'm not depending on other countries for energy anymore. We know how to do it. We have the technology. We should be relying on ourselves."

Baier asked whether the Democratic Party left Manchin, who is generally considered a moderate. 

"I'm a West Virginia Democrat, but I don't know. I don't know where maybe I belong at times, but I believe I'm fiscally responsible and socially compassionate. And you know what? I have a lot of Democrats who feel the same as I do. I have a lot of Republicans feel the same as I do."

Manchin added that he respectfully disagrees with the progressive Democratic wing's guiding philosophy. 

CLICK HERE TO EXTEND YOUR WIFI RANGE AND STREAM VIDEO ON FOX

"This is a shame when we start this war of words ... We can have a difference of opinion – the rhetoric around here has gotten so harsh and so toxic that you can't agree to disagree anymore. You can't sit down and say, 'OK, I disagree with you."

"What scares the bejesus out of me – I don't hear people saying, ‘This is good for our country.’ It's more or less on both sides – It's is better for my party, this is better for the 2022 elections."

Comments

Popular posts from this blog

Who is the first and only President to instigate a coup?

Dark Brandon Vs Donald Hoover Trump

Can MAGA Insurrectionists Launch Attacks Against the Supreme Court Over its Rulings? Exploring the Limits of Political Influence on Judicial Decisions

Can MAGA Insurrectionists Launch Attacks Against the Supreme Court Over its Rulings? Exploring the Limits of Political Influence on Judicial Decisions. In the wake of contentious legal battles and polarizing decisions, the question arises: Can the "Make America Great Again" (MAGA) movement launch attacks against the Supreme Court over its rulings? As the highest court in the land, the U.S. Supreme Court is often a focal point of scrutiny and criticism from various political factions, but the extent to which these attacks can influence or undermine its authority is a matter of debate and legal interpretation. Historical Context:  Throughout American history, the Supreme Court has faced criticism and resistance from various quarters. From landmark decisions on civil rights and social issues to contentious rulings on political matters, the Court has been no stranger to public backlash. However, the principles of judicial independence and the separation of powers enshrined in the

Treatment of erectile dysfunction in adult males aged 22 years and over

  Treatment of erectile dysfunction in adult males aged 22 years and over . U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.0 6 . 0 2 Silver Spring, M D 20993 www.fda.gov June 9, 2023 Re: DEN220078 Trade/Device Name: Eroxon Regulation Number: 21 CFR 876.5021 Regulation Name: Non- medicated top ical formula tion for trea tment of erec tile dysfu nction Regulatory Class: II Product Code: QWW Dated: January 4, 2023 Received: March 28, 2023 Dear Ken James: The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its review of your De Novo request for classification of the Eroxon, an over- the - counter device under 21 CFR Part 801 Subpart C with the following indications for use: Treatment of erectile dysfunction in adult males aged 22 years and over. FDA concludes that this device should be classified into Class II. Th is order, therefor